deCODE Genetics and San Diego-based Illumina have entered into a strategic alliance, said today that the two companies will work together to commercialize DNA-based diagnostics. The two companies said that they will initiate work on molecular diagnostics for heart attack, type 2 diabetes, and other conditions. The two firms will use Illumina's upcoming SNP genotyping platform and deCode's population genetics resources to develop diagnostics for various genetic disorders.
Top NewsMonday, May 15, 2006
deCODE, Illumina In DNA Alliance